Business Context and Reporting Period
This Form 8-K Current Report, filed on September 8, 2025, covers events occurring on September 3, 2025, involving The Dow Chemical Company (a Delaware corporation) and its parent, Dow Inc. The filing details the execution and completion of a debt offering.
Key Financial Metrics and Transaction Details
The Company issued and sold $1.4 billion in aggregate principal amount of notes to underwriters represented by BofA Securities, Inc., Citigroup Global Markets Inc., and SMBC Nikko Securities America, Inc. The offering consisted of two tranches:
- 2031 Notes: $750 million aggregate principal amount with a 4.800% coupon rate.
- 2036 Notes: $650 million aggregate principal amount with a 5.650% coupon rate.
The offering was completed on September 8, 2025. The filing does not provide specific data on revenue, profit, cash flow, operating margins, or existing liquidity positions outside of this transaction.
Material Changes
The primary material change is the increase in long-term debt obligations by $1.4 billion. The Company entered into an Underwriting Agreement on September 3, 2025, and finalized the issuance five days later. No other material changes to operations or financial status are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing does not contain management commentary, forward-looking guidance, or specific risk factors related to future performance. The transaction was executed pursuant to a registration statement on Form S-3 filed on June 13, 2025. The Notes are issued under an Indenture dated July 26, 2019, with The Bank of New York Mellon Trust Company, N.A., as trustee.
Investor Verification Checklist
- Verify the use of proceeds from the $1.4 billion note issuance in the accompanying Underwriting Agreement (Exhibit 1.1).
- Review the specific covenants and default provisions in the Indenture (Exhibit 4.1) and the Note forms (Exhibits 4.2 and 4.3).
- Confirm the impact of the new debt on the Company's total leverage ratios and interest coverage in the next quarterly or annual report.
- Check for any subsequent amendments to the registration statement (File No. 333-288028-01).